Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)

NCT00211380 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Recruitment was too difficult

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: aripiprazole

Sponsor

Louisiana State University Health Sciences Center Shreveport

Collaborators

[object Object]